Market Research Reports

1. India In-Vitro Diagnostics Market Introduction

Market Overview

Growth Drivers

Constraints

Regulatory Framework and Accreditation

 

2. India In-Vitro Diagnostics Market Size by Revenues, FY’2007-FY’2013

 

3. India In-Vitro Diagnostics Market Segmentation

3.1. By Reagents and Instruments, FY’2010-FY’2013

3.2. By Urban and Rural Areas, FY’2013

3.3. By Type of Tests, FY’2007-FY’2013

 

4. India Immunochemistry Market

4.1. Market Scenario

Market Overview

Drivers

Constraints

Emerging Technology Trends

4.2. India Immunochemistry Market Size, FY’2007- FY’2013

4.3. India Immunochemistry Market Segmentation Reagents and Instruments, ELISA Kits and Rapid Tests, FY’2007-FY’2013

4.3.1. India Immunochemistry Instruments and Reagents Market Size, FY’2007-FY’2013

4.3.2. India Immunochemistry Instruments and Reagents Market Segmentation By Type of Tests, FY’2007-FY’2013

4.3.3. India Immunochemistry Reagents Market Segmentation by End Use, FY’2007-FY’2013

4.4. Market Share of Major Players in India Immunochemistry Market, FY’2013

 

5. India Biochemistry Market

5.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

5.2. India Biochemistry Market Size, FY’2007 – FY’2013

5.3. India Biochemistry Market Segmentation by Reagents and Instruments, FY’2007-FY’2013

5.4. Market Share of Major Players in India Biochemistry Market, FY’2013

 

6. India Hematology Market

6.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

6.2. India Hematology Market Size, FY’2007-FY’2013

6.3. India Hematology Market Segmentation By Reagents and Instruments, FY’2007-FY’2013

6.4. India Hematology Market Competitive Landscape

 

7. India Microbiology Market

7.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

7.2. India Microbiology Market Size, FY’2007-FY’2013

7.3. India Microbiology Market Segmentation by Reagents and Instruments, FY’2008-FY’2013

7.4. Market Share of Major Players in India Microbiology Market, FY’2013

 

8. India Blood Gas and Electrolyte Market

8.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

8.2. India Blood Gas and Electrolyte Market Size, FY’2007 - FY’2013

8.3. India Blood Gas and Electrolyte Market Segmentation by Reagents and Instruments, FY’2007-FY’2013

8.4. Market Share of Major Players in India Blood Gas and Electrolyte Market, FY’2013

 

9. India Molecular Diagnostics Market

9.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

9.2. India Molecular Diagnostics Market Size, FY’2007 - FY’2013

9.3. India Molecular Diagnostics Market Segmentation by Reagents and Instruments, FY’2007-FY’2013

 

10. India Urinalysis Market

10.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

10.2. India Urinalysis Market Size, FY’2007 - FY’2013

10.3. India Urinalysis Market Segmentation by Reagents and Instruments, FY’2007-FY’2013

 

11. India Coagulation Diagnostics Market

11.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

11.2. India Coagulation Diagnostics Market Size, FY’2007 – FY’2013

11.3. India Coagulation Diagnostics Market Segmentation by Reagents and Instruments, FY’2007-FY’2013

 

12. India In-Vitro Diagnostics Market Trends and Developments

Mounting Demand for Decentralized Laboratory Tests

Increasing Penetration in Rural Areas

Early Detection as an Emerging Trend

Inclining Automation of Labs

Increasing Consolidation

Increasing Overseas Expansion

Inclining Prevalence of Hospital Laboratory Management (HLM) 

 

13. Market Share of Major Players in India In-Vitro Diagnostics Market, FY’2013

 

14. Company Profiles of Major Players in India In-Vitro Diagnostics Market

 

15. India In-Vitro Diagnostics Market Future Outlook and Projections, FY’2014-FY’2018

15.1. Cause and Effect Relationship Analysis of the In-vitro Diagnostics Market in India

 

16. Macroeconomic and Industry Factors: Historical and Projections

16.1. Population in India, FY’2007-FY’2018

16.2. Personal Disposable Income in India, FY’2007-FY’2018

16.3. Consumer Expenditure on Healthcare in India, FY’2007-FY’2018

16.4. Government Expenditure on Healthcare in India, FY’2007-FY’2018

16.5. Foreign Direct Investments in Healthcare, FY’2008-FY’2013

16.6. Private Equity Investments in Healthcare, 2009-2012

 

17. Appendix

17.1. Market Definitions

17.2. Abbreviations

17.3. Research Methodology

Data Collection Methods

Approach

Variables (Dependent and Independent) 

Final Conclusion

17.4. Disclaimer

India In-Vitro Diagnostics Industry-Market Size Pages : 7 USD 100    Market Size Reports Market Size Reports

 1. India In-Vitro Diagnostics Market Introduction

Market Overview
Growth Drivers
Constraints
Regulatory Framework and Accreditation
2. India In-Vitro Diagnostics Market Size by Revenues, FY’2007-FY’2013
 

India In-Vitro Diagnostics Industry-Market Segmentation Pages : 4 USD 150    Market Size Reports Market Size Reports

 3. India In-Vitro Diagnostics Market Segmentation

3.1. By Reagents and Instruments, FY’2010-FY’2013
3.2. By Urban and Rural Areas, FY’2013
3.3. By Type of Tests, FY’2007-FY’2013
 

India In-Vitro Diagnostics Industry-Immunochemistry Market Pages : 12 USD 150    Market Size Reports Market Size Reports

 4. India Immunochemistry Market

4.1. Market Scenario
Market Overview
Drivers
Constraints
Emerging Technology Trends
4.2. India Immunochemistry Market Size, FY’2007- FY’2013
4.3. India Immunochemistry Market Segmentation Reagents and Instruments, ELISA Kits and Rapid Tests, FY’2007-FY’2013
4.3.1. India Immunochemistry Instruments and Reagents Market Size, FY’2007-FY’2013
4.3.2. India Immunochemistry Instruments and Reagents Market Segmentation By Type of Tests, FY’2007-FY’2013
4.3.3. India Immunochemistry Reagents Market Segmentation by End Use, FY’2007-FY’2013
4.4. Market Share of Major Players in India Immunochemistry Market, FY’2013
 

India In-Vitro Diagnostics Industry-Biochemistry Market Pages : 8 USD 120    Market Size Reports Market Size Reports

 5. India Biochemistry Market

5.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
5.2. India Biochemistry Market Size, FY’2007 – FY’2013
5.3. India Biochemistry Market Segmentation by Reagents and Instruments, FY’2007-FY’2013
5.4. Market Share of Major Players in India Biochemistry Market, FY’2013
 

India In-Vitro Diagnostics Industry-Hematology Market Pages : 8 USD 120    Market Size Reports Market Size Reports

 6. India Hematology Market

6.1. Market Scenario
Market Overview
Growth Drivers
Constraint
Trends
6.2. India Hematology Market Size, FY’2007-FY’2013
6.3. India Hematology Market Segmentation By Reagents and Instruments, FY’2007-FY’2013
6.4. India Hematology Market Competitive Landscape
 

India In-Vitro Diagnostics Industry-Microbiology Market Pages : 6 USD 120    Market Size Reports Market Size Reports

 7. India Microbiology Market

7.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
7.2. India Microbiology Market Size, FY’2007-FY’2013
7.3. India Microbiology Market Segmentation by Reagents and Instruments, FY’2008-FY’2013
7.4. Market Share of Major Players in India Microbiology Market, FY’2013
 

India In-Vitro Diagnostics Industry-Blood Gas and Electrolyte Market Pages : 8 USD 120    Market Size Reports Market Size Reports

 8. India Blood Gas and Electrolyte Market

8.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
8.2. India Blood Gas and Electrolyte Market Size, FY’2007 - FY’2013
8.3. India Blood Gas and Electrolyte Market Segmentation by Reagents and Instruments, FY’2007-FY’2013
8.4. Market Share of Major Players in India Blood Gas and Electrolyte Market, FY’2013
 

India In-Vitro Diagnostics Industry-Molecular Diagnostics Market Pages : 6 USD 120    Market Size Reports Market Size Reports

 9. India Molecular Diagnostics Market

9.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
9.2. India Molecular Diagnostics Market Size, FY’2007 - FY’2013
9.3. India Molecular Diagnostics Market Segmentation by Reagents and Instruments, FY’2007-FY’2013
 

India In-Vitro Diagnostics Industry-Urinalysis Market Pages : 5 USD 100    Market Size Reports Market Size Reports

 10. India Urinalysis Market

10.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
10.2. India Urinalysis Market Size, FY’2007 - FY’2013
10.3. India Urinalysis Market Segmentation by Reagents and Instruments, FY’2007-FY’2013
 

India In-Vitro Diagnostics Industry-Coagulation Diagnostics Market Pages : 5 USD 100    Market Size Reports Market Size Reports

 11. India Coagulation Diagnostics Market

11.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
11.2. India Coagulation Diagnostics Market Size, FY’2007 – FY’2013
11.3. India Coagulation Diagnostics Market Segmentation by Reagents and Instruments, FY’2007-FY’2013
 

India In-Vitro Diagnostics Industry-Trends Pages : 3 USD 50    Market Size Reports Market Size Reports

 12. India In-Vitro Diagnostics Market Trends and Developments

Mounting Demand for Decentralized Laboratory Tests
Increasing Penetration in Rural Areas
Early Detection as an Emerging Trend
Inclining Automation of Labs
Increasing Consolidation
Increasing Overseas Expansion
Inclining Prevalence of Hospital Laboratory Management (HLM)
 

India In-Vitro Diagnostics Industry-Market Share and Profile Pages : 9 USD 150    Market Size Reports Market Size Reports

13. Market Share of Major Players in India In-Vitro Diagnostics Market, FY’2013

14. Company Profiles of Major Players in India In-Vitro Diagnostics Market

 

India In-Vitro Diagnostics Industry-Future Outlook and Macro Economy Pages : 13 USD 150    Market Size Reports Market Size Reports

 15. India In-Vitro Diagnostics Market Future Outlook and Projections, FY’2014-FY’2018

15.1. Cause and Effect Relationship Analysis of the In-vitro Diagnostics Market in India
16. Macroeconomic and Industry Factors: Historical and Projections
16.1. Population in India, FY’2007-FY’2018
16.2. Personal Disposable Income in India, FY’2007-FY’2018
16.3. Consumer Expenditure on Healthcare in India, FY’2007-FY’2018
16.4. Government Expenditure on Healthcare in India, FY’2007-FY’2018
16.5. Foreign Direct Investments in Healthcare, FY’2008-FY’2013
16.6. Private Equity Investments in Healthcare, 2009-2012